Use of ctDNA for Monitoring of Stage III Colorectal Cancer

Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study

NCT04726800 ·Status: ACTIVE_NOT_RECRUITING

Presence of Circulating Tumor DNA in Colorectal Cancer

NCT01198743 ·Status: COMPLETED

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

NCT04624555 ·Status: RECRUITING

Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy

NCT02665299 ·Status: COMPLETED

A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence

NCT02005913 ·Status: UNKNOWN

Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III

NCT02556281 ·Status: COMPLETED ·Phase: NA

Colon Cancer Treatment Decisions and Recurrence Predicting

NCT02997241 ·Status: UNKNOWN ·Phase: NA

Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment

NCT02813928 ·Status: COMPLETED ·Phase: NA

Relapse Markers for Colorectal Cancer

NCT04920955 ·Status: COMPLETED

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

NCT05234177 ·Status: RECRUITING

IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer

NCT03637686 ·Status: ACTIVE_NOT_RECRUITING

Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance

NCT05528783 ·Status: RECRUITING

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

NCT00899626 ·Status: RECRUITING

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT04084249 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes

NCT06852495 ·Status: ACTIVE_NOT_RECRUITING

Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population

NCT01793207 ·Status: COMPLETED

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

NCT00625066 ·Status: COMPLETED

Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers

NCT01828918 ·Status: UNKNOWN ·Phase: PHASE1

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC

NCT04912882 ·Status: NOT_YET_RECRUITING

OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer

NCT04680260 ·Status: RECRUITING ·Phase: PHASE2

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

NCT01934179 ·Status: TERMINATED

Early Detection of Advanced Adenomas and Colorectal Cancer

NCT06342440 ·Status: RECRUITING

Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

NCT03337347 ·Status: COMPLETED ·Phase: NA

Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy

NCT00897403 ·Status: COMPLETED

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

NCT07310446 ·Status: RECRUITING